A combination of Lupkinis (viclosporin) with mycophenolate mofetil (MMF) was the most effective at managing lupus nephritis, according…
Articles by Andrea Lobo, PhD
The National Kidney Foundation (NFK) has launched a patient-friendly video series to help patients better understand the association between…
Certain self-reactive antibodies, called antiphospholipid antibodies (aPLs), significantly increase the risk of a heart attack, stroke, or other cardiovascular event…
This year’s winners of the Lupus Foundation of America‘s Gary S. Gilkeson Career Development Award — designed to support…
Lupus Therapeutics is partnering with AbbVie for the Phase 3 clinical program of upadacitinib for people with…
In a new deal worth up to $132.5 million, Everest Medicines will have the exclusive right to develop and commercialize…
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded $3 million to a research team that’s…
A Canadian researcher will use a newly granted Lupus Canada Catalyst Award — with one year of funding totaling $40,000…
Toni Braxton is hoping to strike a chord with people with lupus via Aurinia Pharmaceuticals‘ “Get Uncomfortable” campaign:…
Viral infections with cytomegalovirus, known as CMV, are highly prevalent in children with systemic lupus erythematosus (SLE), and…